We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$22.1B
AUM Growth
+$302M
Cap. Flow
-$1.3B
Cap. Flow %
-5.9%
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$148M
2
NFLX icon
Netflix
NFLX
+$119M
3
ABNB icon
Airbnb
ABNB
+$111M
4
XYZ
Block Inc
XYZ
+$89.5M
5
DHR icon
Danaher
DHR
+$88.6M

Top Sells

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$212M
2
BABA icon
Alibaba
BABA
+$172M
3
ZTS icon
Zoetis
ZTS
+$133M
4
TRU icon
TransUnion
TRU
+$124M
5
BIDU icon
Baidu
BIDU
+$111M

Sector Composition

Rank Sector Weight
1 Healthcare 20.88%
2 Financials 13.4%
3 Consumer Discretionary 12.06%
4 Technology 11.2%
5 Communication Services 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GROW icon
2001
US Global Investors
GROW
$36.3M
$639K ﹤0.01%
103,310
+19,021
+23% +$136K
MITK icon
2002
Mitek Systems
MITK
$756M
$638K ﹤0.01%
+33,116
New +$557K
ZLAB icon
2003
Zai Lab
ZLAB
$2.07B
$638K ﹤0.01%
+3,605
New +$580K
SCYX icon
2004
SCYNEXIS
SCYX
$37.4M
$635K ﹤0.01%
+10,786
New +$681K
TRNS icon
2005
Transcat
TRNS
$760M
$635K ﹤0.01%
+11,241
New +$586K
BHR
2006
Braemar Hotels & Resorts
BHR
$163M
$633K ﹤0.01%
+101,929
New +$628K
RCEL icon
2007
Avita Medical
RCEL
$137M
$633K ﹤0.01%
+30,828
New +$608K
MRNA icon
2008
Moderna
MRNA
$21.6B
$631K ﹤0.01%
2,684
-67,483
-96% -$12.1M
VMC icon
2009
Vulcan Materials
VMC
$36.8B
$631K ﹤0.01%
+3,625
New +$648K
FLGT icon
2010
Fulgent Genetics
FLGT
$558M
$629K ﹤0.01%
6,823
-49,955
-88% -$3.99M
MIXT
2011
DELISTED
MIX TELEMATICS LIMITED
MIXT
$629K ﹤0.01%
+37,903
New +$535K
RIO icon
2012
Rio Tinto
RIO
$152B
$628K ﹤0.01%
7,483
+2,051
+38% +$176K
VINC
2013
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$628K ﹤0.01%
+2,418
New +$737K
BCIC
2014
BCP Investment Corp
BCIC
$88.3M
$627K ﹤0.01%
26,361
+23,892
+968% +$567K
AVLR
2015
DELISTED
Avalara, Inc.
AVLR
$626K ﹤0.01%
3,867
-54,745
-93% -$7.63M
PICC.WS
2016
CALL
DELISTED
Pivotal Investment Corporation III Redeemable Warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
PICC.WS
$623K ﹤0.01%
+63,915
New +$64.4K
AIH
2017
DELISTED
Aesthetic Medical International Holdings
AIH
$622K ﹤0.01%
78,202
+50,868
+186% +$380K
BEP icon
2018
Brookfield Renewable
BEP
$9.6B
$621K ﹤0.01%
+16,060
New +$636K
NEM icon
2019
CALL
Newmont
NEM
$96.2B
$621K ﹤0.01%
+9,800
New +$657K
TOIIW
2020
CALL
The Oncology Institute Warrant
TOIIW
$4.35M
$621K ﹤0.01%
62,492
– –
VTVT icon
2021
vTv Therapeutics
VTVT
$124M
$621K ﹤0.01%
6,806
+2,381
+54% +$241K
CLPS icon
2022
CLPS Inc
CLPS
$26M
$618K ﹤0.01%
143,722
+61,512
+75% +$264K
KVSA
2023
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
$618K ﹤0.01%
62,500
– –
HEI.A icon
2024
HEICO Corp Class A
HEI.A
$36B
$615K ﹤0.01%
+4,955
New +$627K
THRM icon
2025
Gentherm
THRM
$1.32B
$615K ﹤0.01%
8,651
-4,435
-34% -$323K
79 80
81
82 83

Similar funds

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Marshall Wace's Q2 2021 Portfolio in Review

As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Marshall Wace withdrew a net $1.3B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.

  • Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
  • Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
  • Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
  • Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
  • Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
  • Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
  • Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.